Showing results (101-110 of 272) with videos related to
Sort By:
Pageof 28
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 31, 2012
Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinomaKiong-Ming Wong, Ming-Lun Yeh, Shih-Chung Chuang, et al.Plos One|March 26, 2013
Virological predictors of response to retreatment in hepatitis C genotype 2 infected patientsChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.Journal of Gastroenterology and Hepatology|April 9, 2013
Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirinChung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, et al.Plos One|May 13, 2022
Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patientsBatbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 19, 2012
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotypeChung-Feng Huang, Ming-Lung Yu, Jia-Horng Kao, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2017
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinomaTomi W Jun, Ming-Lun Yeh, Ju Dong Yang, et al.Pageof 28